{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:18:42Z","timestamp":1791065922403,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,10,16]],"date-time":"2013-10-16T00:00:00Z","timestamp":1381881600000},"content-version":"vor","delay-in-days":15,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.jconrel.2013.07.004","type":"journal-article","created":{"date-parts":[[2013,7,13]],"date-time":"2013-07-13T17:48:19Z","timestamp":1373737699000},"page":"216-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["The nanoparticulation by octaarginine-modified liposome improves \u03b1-galactosylceramide-mediated antitumor therapy via systemic administration"],"prefix":"10.1016","volume":"171","author":[{"given":"Takashi","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyoshi","family":"Harashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2013.07.004_bb0005","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/ni1203-1164","article-title":"The NKT cell system: bridging innate and acquired immunity","volume":"4","author":"Taniguchi","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0010","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1126\/science.278.5343.1626","article-title":"CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides","volume":"278","author":"Kawano","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2013.07.004_bb0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1084\/jem.186.1.109","article-title":"Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells","volume":"186","author":"Exley","year":"1997","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0020","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nri2451","article-title":"Harnessing invariant NKT cells in vaccination strategies","volume":"9","author":"Cerundolo","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0025","first-page":"529","article-title":"KRN7000, a novel immunomodulator, and its antitumor activities","volume":"7","author":"Kobayashi","year":"1995","journal-title":"Oncol. Res."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0030","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2174\/156652409788970706","article-title":"The contrasting roles of NKT cells in tumor immunity","volume":"9","author":"Berzofsky","year":"2009","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0035","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.clim.2008.07.025","article-title":"Invariant natural killer T cells and immunotherapy of cancer","volume":"129","author":"Molling","year":"2008","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0040","first-page":"3702","article-title":"A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors","volume":"8","author":"Giaccone","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0045","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.clim.2010.11.010","article-title":"Clinical experience with alpha-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B\/C infection","volume":"140","author":"Schneiders","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0050","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1084\/jem.20042592","article-title":"Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients","volume":"201","author":"Chang","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0055","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1158\/1078-0432.CCR-04-1453","article-title":"A phase I study of alpha-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer","volume":"11","author":"Ishikawa","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0060","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.clim.2011.01.009","article-title":"Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer","volume":"140","author":"Motohashi","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0065","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/mt.2008.122","article-title":"Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes","volume":"16","author":"Nakamura","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0070","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ijpharm.2012.11.006","article-title":"Incorporation of polyinosine-polycytidylic acid enhances cytotoxic T cell activity and antitumor effects by octaarginine-modified liposomes encapsulating antigen, but not by octaarginine-modified antigen complex","volume":"441","author":"Nakamura","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0075","doi-asserted-by":"crossref","first-page":"16800","DOI":"10.1074\/jbc.M110.217224","article-title":"A microbial glycolipid functions as a new class of target antigen for delayed-type hypersensitivity","volume":"286","author":"Komori","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0080","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.bbrc.2011.04.146","article-title":"Glycerol monomycolate, a latent tuberculosis-associated mycobacterial lipid, induces eosinophilic hypersensitivity responses in guinea pigs","volume":"409","author":"Hattori","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0085","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.addr.2004.10.007","article-title":"Intracellular delivery of large molecules and small particles by cell-penetrating proteins and peptides","volume":"57","author":"Gupta","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0090","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1021\/bc015508l","article-title":"Stearylated arginine-rich peptides: a new class of transfection systems","volume":"12","author":"Futaki","year":"2001","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0095","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.1074\/jbc.M503202200","article-title":"High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression","volume":"281","author":"Khalil","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0100","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1016\/j.vaccine.2007.08.062","article-title":"Regulation of airway eosinophil and neutrophil infiltration by alpha-galactosylceramide in a mouse model for respiratory syncytial virus (RSV) vaccine-augmented disease","volume":"25","author":"Benoit","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2013.07.004_bb0105","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbrc.2008.02.037","article-title":"Characterization of the immature dendritic cells and cytotoxic cells both expanded after activation of invariant NKT cells with alpha-galactosylceramide in vivo","volume":"369","author":"Tamura","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijpharm.2011.04.068","article-title":"Activation of invariant Natural Killer T lymphocytes in response to the alpha-galactosylceramide analogue KRN7000 encapsulated in PLGA-based nanoparticles and microparticles","volume":"423","author":"Macho Fernandez","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0115","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.4049\/jimmunol.174.8.4696","article-title":"Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo","volume":"174","author":"Bezbradica","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0120","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jconrel.2012.06.019","article-title":"Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy","volume":"162","author":"Takara","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.07.004_bb0125","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1172\/JCI24762","article-title":"Glycolipid antigen induces long-term natural killer T cell anergy in mice","volume":"115","author":"Parekh","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0130","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nri1631","article-title":"Recognition of lipid antigens by T cells","volume":"5","author":"De Libero","year":"2005","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0135","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.jconrel.2007.03.017","article-title":"New packaging method of mycobacterial cell wall using octaarginine-modified liposomes: enhanced uptake by and immunostimulatory activity of dendritic cells","volume":"120","author":"Homhuan","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.07.004_bb0140","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jconrel.2004.04.024","article-title":"Development of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration method","volume":"98","author":"Kogure","year":"2004","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.07.004_bb0145","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.addr.2007.10.007","article-title":"Multifunctional envelope-type nano device (MEND) as a non-viral gene delivery system","volume":"60","author":"Kogure","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0150","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jconrel.2010.01.012","article-title":"Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation","volume":"143","author":"Akita","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.07.004_bb0155","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1126\/science.6836294","article-title":"Liposomal blockade of the reticuloendothelial system: improved tumor imaging with small unilamellar vesicles","volume":"220","author":"Proffitt","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2013.07.004_bb0160","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nri3244","article-title":"Information processing during phagocytosis","volume":"12","author":"Underhill","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0165","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2567.2006.02335.x","article-title":"Drinking a lot is good for dendritic cells","volume":"117","author":"Norbury","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.jconrel.2013.07.004_bb0170","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0168-3659(01)00549-1","article-title":"Targeting to macrophages: role of physicochemical properties of particulate carriers\u2013liposomes and microspheres\u2013on the phagocytosis by macrophages","volume":"79","author":"Ahsan","year":"2002","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2013.07.004_bb0175","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1440-1711.2001.01011.x","article-title":"Uptake of HIV and latex particles by fresh and cultured dendritic cells and monocytes","volume":"79","author":"Reece","year":"2001","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0180","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1073\/pnas.95.10.5690","article-title":"Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Valpha14 NKT cells","volume":"95","author":"Kawano","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0185","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.immunol.21.120601.141057","article-title":"The regulatory role of Valpha14 NKT cells in innate and acquired immune response","volume":"21","author":"Taniguchi","year":"2003","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0190","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.4049\/jimmunol.163.5.2387","article-title":"Cutting edge: inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide","volume":"163","author":"Toura","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0195","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ni827","article-title":"Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs","volume":"3","author":"Fujii","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0200","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/newbio242148a0","article-title":"Selection of successive tumour lines for metastasis","volume":"242","author":"Fidler","year":"1973","journal-title":"Nat. New Biol."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0205","first-page":"1636","article-title":"In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties","volume":"40","author":"Poste","year":"1980","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2013.07.004_bb0210","first-page":"875","article-title":"Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials","volume":"56","author":"Ishiguro","year":"1996","journal-title":"Cancer Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913003970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913003970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:28:53Z","timestamp":1759159733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365913003970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0168365913003970"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.07.004","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The nanoparticulation by octaarginine-modified liposome improves \u03b1-galactosylceramide-mediated antitumor therapy via systemic administration","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}